Log in to save to my catalogue

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macu...

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfab08f2d69b46e7a3df49bae29c11ea

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectiveWe report the 2-year visual and psychological outcomes of the MERCURY study, examining the long-term effectiveness and safety of ranibizumab and subsequent therapy in Japanese patients with diabetic macular oedema with impaired visual acuity (VA) in the real-world setting.Methods and analysisThis was a 24-month, phase 4, open-label, single...

Alternative Titles

Full title

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dfab08f2d69b46e7a3df49bae29c11ea

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfab08f2d69b46e7a3df49bae29c11ea

Other Identifiers

ISSN

2397-3269

E-ISSN

2397-3269

DOI

10.1136/bmjophth-2022-001069

How to access this item